Form 4: Astrana Health Director Exercises Stock Options and Disposes of Shares

Director John Chiang exercised stock options and disposed of shares of Astrana Health, Inc. on November 19, 2024.

Summary

• On November 19, 2024, John Chiang, a director of Astrana Health, Inc., exercised stock options to acquire 1,515 shares of common stock at a price of $18.41 per share.
• Following the exercise of options, Mr. Chiang disposed of 681 shares of common stock at a price of $40.93 per share.
• After these transactions, Mr. Chiang beneficially owns 16,683 shares of Astrana Health common stock.
• The reported holdings include 4,750 shares of restricted stock vesting on December 9, 2024, and 3,564 shares of restricted stock vesting on the earlier of August 13, 2025, or the date of the Issuer's 2025 annual meeting of stockholders.

Sentiment

Score: 5

Explanation: The document is a neutral report of insider transactions, with no inherent positive or negative sentiment.

Industry Context

This is a standard SEC Form 4 filing, which is common for corporate insiders who trade their company's stock. It provides transparency into the transactions of company directors.

Comparison to Industry Standards

• Form 4 filings are a standard practice for publicly traded companies in the US, ensuring transparency of insider transactions.
• The transactions are typical for directors who may receive stock options as part of their compensation and may sell shares for personal financial management.

Stakeholder Impact

• The transactions may have a minor impact on the stock price, but are generally considered routine insider activity.

Key Dates

Keywords

stock options, insider trading, Form 4, share disposal, restricted stock, Astrana Health, ASTH, director